LeMaitre Vascular Inc (LMAT.OQ) Quote| Reuters.com
Edition:
United States

LeMaitre Vascular Inc (LMAT.OQ)

LMAT.OQ on NASDAQ Stock Exchange Global Market

14.42USD
24 Jun 2016
Change (% chg)

$-0.40 (-2.70%)
Prev Close
$14.82
Open
$14.09
Day's High
$14.51
Day's Low
$14.05
Volume
174,860
Avg. Vol
26,166
52-wk High
$18.42
52-wk Low
$10.62

LMAT.OQ

Chart for LMAT.OQ

About

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical... (more)

Overall

Beta: 0.40
Market Cap(Mil.): $265.03
Shares Outstanding(Mil.): 18.38
Dividend: 0.05
Yield (%): 1.25

Financials

  LMAT.OQ Industry Sector
P/E (TTM): 31.64 46.71 34.11
EPS (TTM): 0.46 -- --
ROI: 11.08 11.65 14.23
ROE: 11.52 13.64 15.46

BRIEF-CryoLife says sale of ProCol distribution rights, purchase option to Lemaitre Vascular

* Cryolife announces sale of Procol distribution rights and purchase option to Lemaitre Vascular Inc.

Mar 18 2016

Competitors

  Price Chg
Terumo Corp (4543.T) ¥4,320 +180.00
Getinge AB (GETIb.ST) 173.80kr --
C R Bard Inc (BCR.N) $226.16 -4.53
Edwards Lifesciences Corp (EW.N) $96.04 -3.04
Cardiovascular Systems Inc (CSII.OQ) $17.60 -0.30

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.